Five things you need to know, and time to celebrate the bean

Good morning, Boston. What an awful ending to this week’s submersible saga. Here are the five things you need to know to start your workday.Meera Raman reports that Needham’s unexpected step toward an IPO this month is being seen by analysts and experts as a smart, opportunistic move — not unlike Eastern Bank's IPO in 2020.The FDA has given the green light to a gene therapy drug to treat Duchenne muscular dystrophy made by Cambridge's Sarepta Therapeutics Inc. after months of d